D18-11141: Phase III Randomized Trial of DFP-10917 vs. Non-Intensive Reinduction (LoDAC, Azacitidine, Decitabine, Ventoclax Combination Regimens) or Intensive Reinduction (High and Intermediate Dose Cytarabine Regimens) for Acute Myelogenous Leukemia Patients in Second, Third, or Fourth Salvage (enrollment paused 13-Oct-2023)

Objective

Clinical Trial Details »

Principal Investigator(s)

Waqas Jehangir, MD

Clinical Trial Categories

• Leukemia

Contact

Hematology Research Coordinators at 605-322-3090
or hematologyresearch@avera.org